Article Versions Notes

Oñate FP, Chamignon C, Burz SD, Lapaque N, Monnoye M, Philippe C, Bredel M, Chêne L, Farin W, Paillarse J-M, et al. Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease. International Journal of Molecular Sciences. 2023; 24(15):12232. https://doi.org/10.3390/ijms241512232

Oñate, Florian Plaza, Célia Chamignon, Sebastian D. Burz, Nicolas Lapaque, Magali Monnoye, Catherine Philippe, Maxime Bredel, Laurent Chêne, William Farin, Jean-Michel Paillarse, and et al. 2023. "Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease" International Journal of Molecular Sciences 24, no. 15: 12232. https://doi.org/10.3390/ijms241512232

Oñate, F. P., Chamignon, C., Burz, S. D., Lapaque, N., Monnoye, M., Philippe, C., Bredel, M., Chêne, L., Farin, W., Paillarse, J.-M., Boursier, J., Ratziu, V., Mousset, P.-Y., Doré, J., Gérard, P., & Blottière, H. M. (2023). Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease. International Journal of Molecular Sciences, 24(15), 12232. https://doi.org/10.3390/ijms241512232